2025
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Muscle & nerve
PubMed • Publisher's siteResearch at a glance
Top areas of exploration
- Myasthenia Gravis , 8 publications
- Amyotrophic Lateral Sclerosis , 5 publications
- Prednisone , 5 publications
- Receptors, Cholinergic , 4 publications
Research activity
My publications
Filter publications
20 publications
2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
The Lancet. Neurology
PubMed • Publisher's site2023
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Amyotrophic lateral sclerosis & frontotemporal degeneration
PubMed • Publisher's site2023
Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis.
Neurology
PubMed • Publisher's site2022
Patient preference for virtual versus in-person visits in neuromuscular clinical practice.
Muscle & nerve
PubMed • Publisher's site